Scientists Discover How To Improve Immune Response To Cancer
Posted on: Monday, 27 April 2009, 08:50 CDT
A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumors.
The findings, published online today in Nature Medicine (DOI: 10.1038/nm.1953), demonstrate the tantalizing potential of immunotherapy in cancer treatment, says principal investigator Dr. Pamela Ohashi, co-director, CFIBCR.
In the lab study, the scientists combined interleukin-7 (IL-7) – a key component of the immune system – with a viral vaccine to improve the ability of the cells of the immune system to attack tumors. The result was clear: The combination boosted immunity to tumors.
"We are extremely excited because our research has revealed the unexpected ways IL-7 works to break down barriers that naturally block the immune response to tumors. This is important because current vaccine approaches for immune therapy induce a response in just 1% to 3% of patients," says Dr. Ohashi, a senior scientist in signaling biology who holds a Canada Research Chair in Autoimmunity and Tumor Immunity. She is also a Professor, University of Toronto, in the Department of Medical Biophysics and Immunology. "
Dr. Tak Mak, co-author and CFIBCR director, says: "The promise of using the body's own defenses to fight cancer is enormous. The day is coming when immunotherapy may help spare cancer patients the toxic side effects of traditional therapies and greatly improve their quality of life while treating the disease. This is why we are planning to expand our immunotherapy research program at PMH." Dr. Mak is also a Professor, University of Toronto, in the Department of Medical Biophysics and Immunology.
This research was also financially supported by grants and fellowships from the Canadian Institute for Health Research, the Ontario Institute for Cancer Research, the Terry Fox Foundation, the National Cancer Institute of Canada, the Boninchi Foundation (Geneva) and the Irvington Institute with the Cancer Research Institute (New York).
---
On the Net:
Related Articles
- Antisoma and The Institute of Cancer Research to Collaborate on Novel Approach to Cancer Treatment
- Institute for Myeloma and Bone Cancer Research Adds Two New Board Members
- National Cancer Research Institute, Japan Validate Predictive Biomarkers on a Clinical Scale Using Nonlinear Dynamics' SameSpots Technology
- Griffin International, Golf Galaxy Announce National Partnership to Benefit Cancer Research Institute
- CN Donates $250,000 to the Atlantic Cancer Research Institute's Discoveries Campaign to Fight Against Cancer
- Cougar Biotechnology Announces CB7630 Phase I Data to Be Presented at National Cancer Research Institute Conference
- GSK Licenses Cancer Antigen Portfolio From Ludwig Institute for Cancer Research
- Cancer Research Institute Starts First Phase I Clinical Trial; New Drug Targets Prostate Cancer Cells
- Pelican Signs Flock to Fish for Cancer-Research Funding: Shores Residents and Barry University Are Teaming Up to Fight Cancer at the Community's Third Annual Relay for Life, and a Flock of Purple Pelicans Are
- Scott & White Cancer Researcher Signs Contract to Help Develop Drugs
 |
 |
User Comments (0)
RSS Feeds